941 / 1241
Wurschmidt et al. Radiation Oncology, 2011
►
18F-Choline PET/CT planning could be helpful in dose
escalation to lymph nodal sites of prostate cancer
19 Pts with recurrent PC
(median PSA: 1.9 ng/ml,
range 0.42 - 65)
Chol+ at Right Obturatoria
LN (SUVmax: 6.0)
IMRT (45 Gy) on pelvic LN
Boost dose (66.6 Gy) on
positive LN
PET/CT as guide for MDT